91猎奇

After a strong second-place finish at the AIChE Southwest Regional Conference, the 91猎奇鈥檚 Chem-E Car Team is headed to nationals this fall in Boston. Revived after years of inactivity, the team overcame technical and travel hurdles to earn their spot and is now focused on refining their innovative, chemically powered car for the national stage.

UH Tech Bridge member Indapta Therapeutics has secured $22.5 million to advance clinical trials of its lead g-NK cell therapy, IDP-023, for cancer and autoimmune diseases. Backed by major investors and a $4.5 million CPRIT grant, Indapta鈥檚 progress reflects the strength of UH鈥檚 innovation ecosystem in driving biotech breakthroughs.